Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists

PURPOSE: This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. PRINCIPAL RESULTS: 92% of responding neurologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezaei, Shawheen J., Vogel, Andre C., Gazdag, Brittany, Alakel, Nicholas, Kumar, Aditya Ravi, Mateen, Farrah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351672/
https://www.ncbi.nlm.nih.gov/pubmed/32682142
http://dx.doi.org/10.1016/j.jneuroim.2020.577320
_version_ 1783557484653314048
author Rezaei, Shawheen J.
Vogel, Andre C.
Gazdag, Brittany
Alakel, Nicholas
Kumar, Aditya Ravi
Mateen, Farrah J.
author_facet Rezaei, Shawheen J.
Vogel, Andre C.
Gazdag, Brittany
Alakel, Nicholas
Kumar, Aditya Ravi
Mateen, Farrah J.
author_sort Rezaei, Shawheen J.
collection PubMed
description PURPOSE: This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. PRINCIPAL RESULTS: 92% of responding neurologists considered their NMO patients to be at an elevated risk of acquiring Covid19. They also indicated sharp declines in visits, delays in treatment and related services, and several unmet needs deterring treatment. MAJOR CONCLUSIONS: There is a need for evidence-based, comprehensive guidelines for treating NMO patients amid healthcare crises moving forward.
format Online
Article
Text
id pubmed-7351672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73516722020-07-13 Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists Rezaei, Shawheen J. Vogel, Andre C. Gazdag, Brittany Alakel, Nicholas Kumar, Aditya Ravi Mateen, Farrah J. J Neuroimmunol Article PURPOSE: This study reports and analyzes the findings from the responses of 192 neurologists in the United States and Canada to a new survey instrument distributed in April 2020 to assess NMO practice and prescribing changes during the Covid19 pandemic. PRINCIPAL RESULTS: 92% of responding neurologists considered their NMO patients to be at an elevated risk of acquiring Covid19. They also indicated sharp declines in visits, delays in treatment and related services, and several unmet needs deterring treatment. MAJOR CONCLUSIONS: There is a need for evidence-based, comprehensive guidelines for treating NMO patients amid healthcare crises moving forward. Elsevier B.V. 2020-09-15 2020-07-11 /pmc/articles/PMC7351672/ /pubmed/32682142 http://dx.doi.org/10.1016/j.jneuroim.2020.577320 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Rezaei, Shawheen J.
Vogel, Andre C.
Gazdag, Brittany
Alakel, Nicholas
Kumar, Aditya Ravi
Mateen, Farrah J.
Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title_full Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title_fullStr Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title_full_unstemmed Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title_short Neuromyelitis optica practice and prescribing changes in the setting of Covid19: A survey of neurologists
title_sort neuromyelitis optica practice and prescribing changes in the setting of covid19: a survey of neurologists
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351672/
https://www.ncbi.nlm.nih.gov/pubmed/32682142
http://dx.doi.org/10.1016/j.jneuroim.2020.577320
work_keys_str_mv AT rezaeishawheenj neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists
AT vogelandrec neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists
AT gazdagbrittany neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists
AT alakelnicholas neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists
AT kumaradityaravi neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists
AT mateenfarrahj neuromyelitisopticapracticeandprescribingchangesinthesettingofcovid19asurveyofneurologists

Ejemplares similares